Diagnostics · 2021 · 24 citations · 7 references
Veterinary MedicineClinical SciencesInfectious DiseasesImmunopathologyInflammationPulmonary Function TestingInflammatory BiomarkersInflammatory SignalingPulmonary Function AssessmentPulmonary InflammationRespiratory DiseaseRespiratory PathologyBiomarkersLung Disease Severity GradingLung Inflammation BiomarkersOxidative BiomarkersPulmonary Disease Severity GradingPulmonary Oxidative Stress
It is essential to find new biomarkers for severity stratification of patients with coronavirus disease (COVID-19). Growth differentiation factor 15 (GDF-15) is upregulated in pathological conditions that involve inflammation and/or oxidative stress. We determined circulating levels of GDF-15 and correlated them with clinical and laboratory parameters reflecting severity in 84 patients with COVID-19, finding that GDF-15 levels were higher in both patients than in 20 healthy controls and were higher in patients with poorer respiratory function. GDF-15 levels also correlated with interleukin-6, C-reactive protein, ferritin and D-dimer levels and with neutrophilia and lymphopenia. Of all the analysed biomarkers, GDF-15 showed the best area under the receiver operating characteristics curve in identifying patients with poor respiratory function. In conclusion, our data support GDF-15 as a biomarker associated with pulmonary impairment in COVID-19 and so can potentially be useful in stratifying COVID-19 cases by severity.
7
Peder L. Myhre, Christian Prebensen, Heidi Strand et al. · Circulation · 2020 · 111 citations · Full text
Veterinary Medicine, Clinical Sciences, Infectious Diseases +17